News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
693,421 Results
Type
Article (39421)
Company Profile (250)
Press Release (653750)
Section
Business (204046)
Career Advice (2006)
Deals (35409)
Drug Delivery (93)
Drug Development (80961)
Employer Resources (169)
FDA (16138)
Job Trends (14832)
News (344921)
Policy (32480)
Tag
Academia (2537)
Alliances (49328)
Alzheimer's disease (1317)
Approvals (16124)
Artificial intelligence (208)
Bankruptcy (357)
Best Places to Work (11637)
Biotechnology (178)
Breast cancer (230)
Cancer (1767)
Cardiovascular disease (132)
Career advice (1670)
CAR-T (128)
Cell therapy (368)
Clinical research (65342)
Collaboration (687)
Compensation (379)
COVID-19 (2568)
C-suite (171)
Data (1686)
Diabetes (220)
Diagnostics (6298)
Earnings (85644)
Employer resources (145)
Events (111093)
Executive appointments (583)
FDA (17076)
Funding (617)
Gene therapy (252)
GLP-1 (657)
Government (4362)
Healthcare (18783)
Infectious disease (2685)
Interviews (311)
IPO (16467)
Job creations (3628)
Job search strategy (1421)
Layoffs (440)
Legal (7890)
Lung cancer (258)
Manufacturing (241)
Medical device (13275)
Medtech (13280)
Mergers & acquisitions (19332)
Metabolic disorders (570)
Neuroscience (1733)
NextGen: Class of 2025 (6510)
Non-profit (4477)
Northern California (2173)
Obesity (313)
Opinion (196)
Patents (174)
People (56892)
Phase I (20346)
Phase II (28782)
Phase III (21432)
Pipeline (779)
Postmarket research (2563)
Preclinical (8586)
Radiopharmaceuticals (242)
Rare diseases (330)
Real estate (5897)
Regulatory (21973)
Research institute (2314)
Resumes & cover letters (349)
Southern California (1862)
Startups (3569)
United States (19107)
Vaccines (620)
Weight loss (213)
Date
Today (74)
Last 7 days (802)
Last 30 days (2651)
Last 365 days (34307)
2025 (5299)
2024 (35223)
2023 (40076)
2022 (51174)
2021 (55710)
2020 (54083)
2019 (46540)
2018 (35019)
2017 (32109)
2016 (31483)
2015 (37556)
2014 (31321)
2013 (26346)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (717)
Arizona (211)
Asia (37548)
Australia (6138)
California (4950)
Canada (1746)
China (410)
Colorado (225)
Connecticut (234)
Europe (80487)
Florida (730)
Georgia (171)
Illinois (462)
Indiana (270)
Japan (126)
Maryland (757)
Massachusetts (3765)
Michigan (200)
Minnesota (344)
New Jersey (1401)
New York (1417)
North Carolina (853)
Northern California (2173)
Ohio (174)
Pennsylvania (1128)
South America (1093)
Southern California (1862)
Texas (725)
Utah (153)
Washington State (474)
693,421 Results for "obio inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
OBiO Technology will showcase at American Society of Gene & Cell Therapy
OBiO Technology Corp., Ltd. will showcase at American Society of Gene & Cell Therapy in Maryland, USA from May 7th to 11th.
April 28, 2024
·
3 min read
Press Releases
OBIO® and CATTI Collaborate to Boost Canada’s Biomanufacturing Capacity for Advanced Therapies
November 4, 2024
·
3 min read
OBiO Technology Officially Launched the Center for Clinical Evaluation and Translation of Advanced Therapies for Pediatric Rare and Genetic Diseases
On May 23, OBiO Technology, a world leading contract development and manufacturing organization for cell and gene therapy, officially launched the “Center for Clinical Evaluation and Translation of Advanced Therapies for Pediatric Rare and Genetic Diseases” at the 2024 Global Rare Disease Research Symposium and the 2nd China Rare Disease Research and Translational Medicine Conference.
May 30, 2024
·
6 min read
OBiO Announces Strategic Partnership with Refreshgene to Realize Commercialization of Gene Therapy Product
OBiO Technology Corp., Ltd., a world leading contract development and manufacturing organization for cell and gene therapy, officially announced an agreement with Refreshgene Therapeutics.
October 24, 2023
·
4 min read
Press Releases
OBiO Technology Congratulates on The First Clinical Gene Editing Therapy to Treat An Overseas Patient in China by CorrectSequence Therapeutics
August 6, 2024
·
3 min read
PurMinds NeuroPharma Selected to Present at the 2024 OBIO Investment Summit
PurMinds NeuroPharma Inc. (“PurMinds™" or the “Company”), a clinical-stage neuroscience company dedicated to the development of innovative therapies for neurological and neurodegenerative disorders
February 6, 2024
·
4 min read
FDA Accepts GMP Plasmid DMF of OBiO Technology
OBiO Technology (Shanghai) Corp., Ltd. (‘OBiO’, 688238.SH), a gene and cell therapy-focused contract research organization (CRO) and contract development and manufacturing organization (CDMO), recently announced that the United States Food and Drug Administration (FDA) has accepted its GMP plasmid DNA drug master file (DMF), DMF Number 037766.
January 16, 2023
·
3 min read
Derm-Biome Pharmaceuticals to Present at the 2023 OBIO Investment Summit on February 10, 2023
Derm-Biome Pharmaceuticals, Inc, a Vancouver based biopharmaceutical company focused on skin health, is pleased to announce that it has been invited to present at the 2023 OBIO Investment Summit (OIS) in Toronto on Friday, February 10th at 11:51am EST.
February 7, 2023
·
1 min read
Pharm Country
Orchestra BioMed Announces Further Details on In-Person R&D Day in New York Featuring Key Opinion Leaders to Discuss AVIM Therapy Program in Hypertensive Pacemaker Patients on June 11, 2024
Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, today announced further details on its in-person R&D day at the Lotte New York Palace Hotel on Tuesday, June 11, 2024, at 10:00 AM ET.
June 4, 2024
·
6 min read
Business
Orchestra BioMed Reports First Quarter 2024 Financial Results and Provides a Business Update
Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, today reported its first quarter 2024 financial results and provided a business update.
May 13, 2024
·
13 min read
1 of 69,343
Next
